The treatment of Eye Health & Vertigo with vitamins

Eye Health and Vertigo: Mitamins custom make quality formulas for the treatment of Eye Health & Vertigo with vitamins. A Eye Health & Vertigo formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Eye Health and Vertigo

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Vitamin B6
    50
    mg
    2500%
    Inositol
    50
    mg
    *
    Lutein
    1000
    mcg
    *
  • Amount Per Serving
    % DV
    Bilberry Extract
    50
    mg
    *
    Bioflavonoid Concentrate
    50
    mg
    *
    Ginkgo Extract
    80
    mg
    *
    N-Acetyl L-Cysteine
    100
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Eye Health and Vertigo Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Victims Of Child Maltreatment More Likely To Perpetrate Youth Violence, Intimate Partner Violence
Some people are caught in a cycle of violence, perhaps beginning with their own abuse as a child and continuing into perpetration or victimization as an adult. To interrupt this cycle, it is important to understand how childhood experiences are related to behavior later in life.
Savient Announces Completion Of Patient Enrollment In Phase 3 Trials Of Puricase® For Treatment-Failure Gout
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced today that it has reached its Phase 3 enrollment target of 200 patients total, in the two replicate placebo-controlled six-month clinical trials. The trials assess the safety and efficacy of Puricase in patients with treatment-failure gout, under the auspices of a Special Protocol Assessment from the U.S. Food and Drug Administration.
This information concerning the support of Eye Health and Vertigo treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments